News Daily News CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials Caitlin E. Cox December 11, 2019
News Conference News ESC 2019 GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS Yael L. Maxwell September 10, 2019
News Conference News ESC 2019 Young MI Patients’ Ischemic Risk Extends at Least Two Decades Caitlin E. Cox September 06, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
News Daily News Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence Yael L. Maxwell May 17, 2019
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017
News Daily News ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention Caitlin E. Cox April 11, 2014
News Daily News Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin August 30, 2013
News Daily News JAMA Review Tackles Intricacies of Medical Therapy After PCI Caitlin E. Cox July 11, 2013
News Daily News Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI Caitlin E. Cox June 20, 2013
News Daily News High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit L.A. McKeown December 19, 2012